Log in to save to my catalogue

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS P...

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS P...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5887953

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS

About this item

Full title

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS

Publisher

US: Oxford University Press

Journal title

Schizophrenia bulletin, 2018-04, Vol.44 (suppl_1), p.S364-S364

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
Cannabis has been associated with higher risk to develop psychosis and worse long-term outcomes. Cannabis use in 2016 is estimated to be 11.3% in Chile in 2016 (SENDA 2016). As in many other countries, cannabis use has steadily increased during last 20 years, across all socioeconomic groups, but especially in men and in th...

Alternative Titles

Full title

S101. CLINICAL FACTORS ASSOCIATED WITH CANNABIS USE IN A CHILEAN SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5887953

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5887953

Other Identifiers

ISSN

0586-7614

E-ISSN

1745-1701

DOI

10.1093/schbul/sby018.888

How to access this item